Our results revealed a regulatory axis by which elevated GAS6 secreted by reactive astrocytes activates the receptor AXL on the surface of BrM-CSCs, which induces the transcription of CD146, highlighting the role of the TME in engaging the mesenchymal transformation of CTCs and tumor angiogenesis. The gene discussed is GAS6; the disease is neoplasm.